Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
05/25/2023 | MANNKIND CORP | MNKD | Grant | Restricted Stock Unit | 210k | $0.00 | $0 | | 05/25/2023 |
03/03/2021 | Acorda Therapeutics, Inc. | ACOR | Grant | Common Stock | 11.1k | $0.00 | $0 | | 03/03/2021 |
09/17/2020 | Acorda Therapeutics, Inc. | ACOR | Grant | Common Stock | 3k | $0.00 | $0 | | 09/17/2020 |
11/07/2019 | Acorda Therapeutics, Inc. | ACOR | Grant | Employee Stock Option (right to buy) | 80k | $2.41 | $192.8k | | 11/07/2019 |
03/08/2019 | Acorda Therapeutics, Inc. | ACOR | Grant | Common Stock | 9k | $0.00 | $0 | | 03/08/2019 |
03/08/2019 | Acorda Therapeutics, Inc. | ACOR | Grant | Employee Stock Option (right to buy) | 15.1k | $13.51 | $203.7k | | 03/08/2019 |
03/08/2019 | Acorda Therapeutics, Inc. | ACOR | Grant | Employee Stock Option (right to buy) | 15k | $13.51 | $202.6k | | 03/08/2019 |
12/22/2018 | Acorda Therapeutics, Inc. | ACOR | Grant | Common Stock | 2.1k | $0.00 | $0 | | 12/22/2018 |
09/10/2018 | Acorda Therapeutics, Inc. | ACOR | Grant | Common Stock | 2.1k | $0.00 | $0 | | 09/10/2018 |
08/01/2018 | Acorda Therapeutics, Inc. | ACOR | Sale | Common Stock | 6.2k | $24.69 | $154.3k | | 08/01/2018 |
08/01/2018 | Acorda Therapeutics, Inc. | ACOR | Exercise | Employee Stock Option (right to buy) | 6.2k | $16.50 | $103.1k | | 08/01/2018 |
07/02/2018 | Acorda Therapeutics, Inc. | ACOR | Sale | Common Stock | 2.1k | $29.26 | $62.6k | | 07/02/2018 |
07/02/2018 | Acorda Therapeutics, Inc. | ACOR | Sale | Common Stock | 2.9k | $29.87 | $85.4k | | 07/02/2018 |
05/18/2018 | Acorda Therapeutics, Inc. | ACOR | Sale | Common Stock | 25k | $23.66 | $591.6k | | 05/18/2018 |
05/18/2018 | Acorda Therapeutics, Inc. | ACOR | Exercise | Employee Stock Option (right to buy) | 25k | $16.50 | $412.5k | | 05/18/2018 |
12/01/2017 | Acorda Therapeutics, Inc. | ACOR | Sale | Common Stock | 11k | $20.53 | $226.9k | | 12/01/2017 |
12/01/2016 | Acorda Therapeutics, Inc. | ACOR | Sale | Common Stock | 10k | $20.74 | $207.4k | | 12/01/2016 |